Allergan

Allergen builds case for first drug therapy for presbyopia
Pharmaforum
Mon, 07/26/21 - 09:35 am
Allergan
presbyopia
AGN-190584
Can Evolus Disrupt the Botox Market?
Motley Fool
Mon, 07/5/21 - 09:47 pm
Evolus
Allergan
Jeuveau
Botox
aesthetics
AbbVie's Botox rolls out the red carpet for real people in new documentary-style ads
Fierce Pharma
Wed, 06/9/21 - 11:08 am
Botox
Allergan
DTC advertising
AbbVie revives DTC ads for dry eye med Restasis with a patient front and center
Fierce Pharma
Mon, 04/26/21 - 10:48 am
Allergan
Restasis
dry eye disease
DTC advertising
television ads
Johnson & Johnson, AbbVie, Teva and Endo to face pharma's first opioid trial since 2019
Fierce Pharma
Mon, 04/19/21 - 12:13 pm
JNJ
AbbVie
Allergan
Teva Pharmaceutical
Endo
opioids
opioid crisis
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
Tue, 03/16/21 - 11:04 am
AbbVie
Women's Health
Allergan
Humira
M&A
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
Tue, 01/5/21 - 10:17 am
AbbVie
Allergan
M&A
Sosei
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Biopharma Reporter
Tue, 12/22/20 - 10:51 am
Aji Biopharma
ReVance
drug manufacturing
aesthetics
daxiabotulinumtoxinA
Botox
Allergan
AbbVie
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
Fierce Pharma
Thu, 12/17/20 - 06:26 pm
AbbVie
Allergan
Botox
ITC
Evolus
Jeuveau
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
Wed, 12/9/20 - 10:39 am
AbbVie
Allergan
Humira
Rinvoq
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
BioSpace
Fri, 11/13/20 - 12:49 pm
dry eye disease
Novartis
Allergan
Sun Pharma
Bausch
Kala Pharmaceuticals
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Wed, 10/28/20 - 10:50 am
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584
AbbVie’s Allergan Aesthetics brand gets a facelift
Fierce Pharma
Tue, 10/20/20 - 10:33 pm
AbbVie
Allergan
aesthetics
branding
Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Endpoints
Thu, 10/1/20 - 10:01 am
Lysosomal Therapeutics
Allergan
R&D
M&A
Henri Termeer
Bial
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
NASDAQ
Thu, 09/10/20 - 11:06 pm
Vesper Healthcare Acquisition
Brent Saunders
Allergan
SPAC
IPOs
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
Xconomy
Thu, 08/27/20 - 10:22 pm
AbbVie
Urogen
overactive bladder
Allergan
Botox
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Fri, 08/7/20 - 10:52 am
Editas Medicine
Allergan
AbbVie
gene editing
CRISPR
AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus
Fierce Pharma
Wed, 07/8/20 - 11:52 pm
AbbVie
Allergan
Evolus
Botox
Jeuveau
Daewoong Pharmaceuticals
FDA rejects AbbVie's eye drug, citing safety concerns
BioPharma Dive
Fri, 06/26/20 - 01:00 pm
Allergan
AbbVie
FDA
abicipar
Molecular Partners
wet age-related macular degeneration

Pages